Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-15

FDA Approved: SIROLIMUS — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved Rising Pharma Holdings, Inc.'s original application for sirolimus, a generic immunosuppressant used to prevent organ transplant rejection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sirolimus (Sirolimus)

Snippet

ORIG AP for SIROLIMUS (SIROLIMUS)